Skip to main content

View full-text article in PMC

. 2012 Dec 28;7(12):e52878. doi: 10.1371/journal.pone.0052878

Table 1. CBC and plasma hemostasis parameters.

Human	Fibrinogen (mg/dl)	PT (sec)	aPTT (sec)	Platelets^c (×10³/µl)	Hemoglobin (g/dl)	WBC (×10³/µl)
Controls^a	272±13	11.5±0.2	32.0±1.1	227±36 24%, 1–2 µm^d 76%, 2–4 µm^d	13.9±0.4	7.1±0.5
BSS-1^b	264; 261	nd; 11.2	33.5; 29.4	37±7 28%, 1–2 µm^d 68%, 2–4 µm^d 4%, 4–8 µm^d	11.5; 11.7	5.8; 6.7
BSS-2^b	384; 317; 351	10.9; 10.5; 10.4	24.9; 26.3; 26.3	59; 32 0; 14%, 1–2 µm^d 17; 5%, 2–4 µm^d 66; 38%, 4–8 µm^d 17; 43%, 8–12 µm^d	13.6; 13.6	7.5; 9.3
GT-1^b	402; 428; 390	9.9; 10.5; 10.2	24.7; 26.6; 25.6	130; 130; 117 3%, 1–2 µm^d 53%, 2–4 µm^d 43%, 4–6 µm^d 2%, 6–8 µm^d	12.8; 13.5; 13.2	3.4; 3.5; 3.7
GT-2	282	10.8	25.6	202 4%, 1–2 µm^d 68%, 2–4 µm^d 28%, 4–6 µm^d	11.2	8.7
GT-3	337	10.2	27.0	224 3%, 1–2 µm^d 72%, 2–4 µm^d 25%, 4–8 µm^d	13.7	7.9

^a

Normal human controls, N = 10.

^b

Data are from separate blood draws >4 months apart.

^c

Manual counts with Wright stain.

^d

Average size distribution of platelets.